Comparative Pharmacology
Head-to-head clinical analysis: DURAGESIC 25 versus PALLADONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DURAGESIC 25 versus PALLADONE.
DURAGESIC-25 vs PALLADONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fentanyl is a mu-opioid receptor agonist that produces analgesia and sedation by mimicking endogenous opioids in the central nervous system.
Agonist at mu-opioid receptors, modulating pain perception via central and peripheral pathways.
Apply 25 mcg/hour transdermally every 72 hours; initial dose in opioid-naive patients: 25 mcg/hour is not recommended; use lower strength or immediate-release opioid first.
Immediate-release: 4-8 mg orally every 4-6 hours as needed for pain; extended-release: 8 mg orally every 12 hours, titrated based on response and tolerance.
None Documented
None Documented
Terminal elimination half-life 22-25 hours (range 13-31 h) after 72-h transdermal application; prolonged in elderly, hepatic or renal impairment
Terminal elimination half-life is approximately 18 hours (range 12-24 h); supports extended dosing intervals.
Renal (75% as metabolites, <10% unchanged); fecal (9%)
Primarily renal (90%) as unchanged drug and glucuronide conjugate; ~10% biliary/fecal.
Category C
Category C
Opioid Analgesic
Opioid Analgesic